NantHealth buys Harris

Genomics company NantHealth has bought systems integrator Harris Healthcare Solutions for an undisclosed sum.

NantHealth is a subsidiary of NantWorks; a cloud-based information technology provider combining genomic science and big data.

Harris Healthcare is a clinical systems integration innovator with around 170 staff, many of whom are based in the UK. Harris retained its US government healthcare services business and financial terms of the transaction were not disclosed.

Harris’ systems include business intelligence tools and patient and clinical portals and are used at a number of NHS trusts including NHS Fife and The Royal Liverpool and Broadgreen University Hospitals NHS Trust.

NantHealth has developed the NantOmics Analytics Platform for genomics sequencing interpretation and annotation and was recently announced as one of the four companies that will work on the government’s ambitious 100,000 Genome Project.

“The acquisition of Harris Healthcare Solutions brings unique and proven technology that significantly furthers our stated goal to improve patient outcomes by efficiently providing healthcare professionals with integrated, clinically relevant patient-centric information in real-time,” said Dr. Patrick Soon-Shiong, chief executive and founder of NantHealth.

“At the same time, we have added an extensive client base of leading clinical and health IT innovators across North America and Europe, as well as a talented and experienced leadership team.”

Former president of Harris and now senior vice president at NantHealth Vishal Agrawal said the new integrated product offering, “creates a healthcare informatics powerhouse with the scale, capabilities and depth to deliver even greater value to our clients.” 

Digital Health News reported last week that NantHealth and electronic patient record provider Allscripts had cross-invested £300 million in each other’s businesses.